FERMENTALG (ALGAE.PA)

EUR 0.44

(0.0%)

Operating Income Summary of FERMENTALG

  • FERMENTALG's latest annual operating income in 2023 was -11.8 Million EUR , down -39.49% from previous year.
  • FERMENTALG's latest quarterly operating income in 2024 Q2 was -2.17 Million EUR , down 0.0% from previous quarter.
  • FERMENTALG reported an annual operating income of -9.27 Million EUR in 2022, down -5.54% from previous year.
  • FERMENTALG reported an annual operating income of -8.78 Million EUR in 2021, up 0.96% from previous year.
  • FERMENTALG reported a quarterly operating income of -2.17 Million EUR for 2024 Q1, up 39.69% from previous quarter.
  • FERMENTALG reported a quarterly operating income of -3.6 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Operating Income Chart of FERMENTALG (2023 - 2019)

Created with Highcharts 11.1.0YearsOperating Income20192019.520202020.520212021.520222022.52023-14000000 EUR-13000000 EUR-12000000 EUR-11000000 EUR-10000000 EUR-9000000 EUR-8000000 EUR

Historical Annual Operating Income of FERMENTALG (2023 - 2019)

Year Operating Income Operating Income Growth
2023 -11.8 Million EUR -39.49%
2022 -9.27 Million EUR -5.54%
2021 -8.78 Million EUR 0.96%
2020 -8.86 Million EUR 34.85%
2019 -13.61 Million EUR 0.0%

Peer Operating Income Comparison of FERMENTALG

Name Operating Income Operating Income Difference
Nicox S.A. -17.5 Million EUR 32.537%
European Medical Solutions -135 Thousand EUR -8646.667%
argenx SE -417.15 Million EUR 97.169%
BioSenic S.A. -7.04 Million EUR -67.727%
Celyad Oncology SA -8.45 Million EUR -39.624%
Hyloris Pharmaceuticals SA -15.99 Million EUR 26.168%
Onward Medical N.V. -35.46 Million EUR 66.703%
Oxurion NV -12.11 Million EUR 2.494%
PHAXIAM Therapeutics S.A. -23.66 Million EUR 50.093%
Financière de Tubize SA -2.14 Million EUR -450.753%
UCB SA 604 Million EUR 101.955%